Press release
Global Irritable Bowel Syndrome (Ibs) Market Is Projected To Reach Us$ 10960 Million By 2027, From Us$ 4130.9 Million In 2020, At A Cagr Of 15.0% During 2021-2027-
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%. North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share. Market Analysis and Insights: Global Irritable Bowel Syndrome (IBS) Market The global Irritable Bowel Syndrome (IBS) market size is projected to reach US$ 10960 million by 2027, from US$ 4130.9 million in 2020, at a CAGR of 15.0% during 2021-2027-
Request Sample Report and Full Report TOC:
https://www.qyresearch.com/sample-form/form/3233918/global-and-united-states-irritable-bowel-syndrome-ibs-market
The Essential Content Covered in the Global and United States Irritable Bowel Syndrome (IBS) Market Report :
* Top Key Company Profiles.
* Main Business and Rival Information
* SWOT Analysis and PESTEL Analysis
* Production, Sales, Revenue, Price and Gross Margin
* Market Share and Size
Top Players of and United States Irritable Bowel Syndrome (IBS) Market are Studied: Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals
The report provides a 6-year forecast (2021-2027) assessed based on how the and United States Irritable Bowel Syndrome (IBS) market is predicted to grow in major regions like USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.
Segmentation by Type: IBS-D Drug
IBS-C Drug
Others Irritable Bowel Syndrome (IBS)
Segmentation by Application: Women
Men
Get Full Customize report or for any Special Discount visit@
https://www.qyresearch.com/customize-request/form/3233918/global-and-united-states-irritable-bowel-syndrome-ibs-market
Reasons to Buy this Report:
Industry Size & Forecast: Estimations on the global and United States Irritable Bowel Syndrome (IBS) industry size on the basis of value and volume are provided in this part of the report
Study on Key Industry Trends: This section offers deep insights into the prevailing and upcoming and United States Irritable Bowel Syndrome (IBS) trends
Segmental Analysis: Here, the report has examined the high-growth segments including product type, application, and end-users, taking into account their CAGR, share, and size
Future Prospects: Current and United States Irritable Bowel Syndrome (IBS) developments and future opportunities estimated to emerge in the and United States Irritable Bowel Syndrome (IBS) industry are looked into in this portion of the study
Geography-wise Analysis: The authors of the report have studied the regions having growth potential to help companies plan their future investments
Study on Competitive Landscape: The industry experts have offered thorough information about the strategic tactics adopted by the industry participants to consolidate their position. This assessment will help the players to strategize their activities in future.
Buy Now this Report at USD(3900): https://www.qyresearch.com/settlement/pre/6ab20e16f5540079b42aaac30adcb306,0,1,global-and-united-states-irritable-bowel-syndrome-ibs-market
TOC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2016-2027)
2.2 Irritable Bowel Syndrome (IBS) Growth Trends by Regions
2.2.1 Irritable Bowel Syndrome (IBS) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Share by Regions (2016-2021)
2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2022-2027)
2.3 Irritable Bowel Syndrome (IBS) Industry Dynamic
2.3.1 Irritable Bowel Syndrome (IBS) Market Trends
2.3.2 Irritable Bowel Syndrome (IBS) Market Drivers
2.3.3 Irritable Bowel Syndrome (IBS) Market Challenges
2.3.4 Irritable Bowel Syndrome (IBS) Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2016-2021)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2021)
3.2 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
3.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2020
3.5 Irritable Bowel Syndrome (IBS) Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome (IBS) Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Irritable Bowel Syndrome (IBS) Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2016-2021)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2022-2027) 5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2016-2021)
5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2022-2027) 6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
6.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type
6.2.1 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
6.2.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
6.2.3 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application
6.3.1 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
6.3.2 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
6.3.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country
6.4.1 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
6.4.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada 7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
7.2.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
7.2.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
7.2.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
7.3.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
7.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
7.3.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
7.4.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
7.4.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic 8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type
8.2.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application
8.3.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region
8.4.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
9.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type
9.2.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
9.2.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
9.2.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
9.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application
9.3.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
9.3.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
9.3.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
9.4 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country
9.4.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
9.4.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type
10.2.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application
10.3.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country
10.4.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.1.5 Bausch Health Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
11.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
11.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Company Details
11.5.2 Sebela Pharmaceuticals Inc Business Overview
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
11.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.5.5 Sebela Pharmaceuticals Inc Recent Development
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Company Details
11.6.2 Astellas Pharmaceuticals Business Overview
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.6.5 Astellas Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com
About Us
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Irritable Bowel Syndrome (Ibs) Market Is Projected To Reach Us$ 10960 Million By 2027, From Us$ 4130.9 Million In 2020, At A Cagr Of 15.0% During 2021-2027- here
News-ID: 2313913 • Views: …
More Releases from QY Research, Inc
Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales P …
High Pressure Commercial Toilet also means pressure-flushing toilets. Pressure-flushing toilets are especially common in cities in the U.S. The ceramic tank is not used as a water tank. It holds a plastic pressure vessel of maybe one-third to one-half the ceramic tank"s volume. That pressure tank contains a sealed air bladder. When the tank is filled from the water supply line, the tank fills with water until the air bladder…
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and …
Twin-Screw Pumps is a displacement pump consisting of a casing containing two parallel screws with intermeshing threads fitted to prevent backward movement of fluid
The global Twin-Screw Pumps market was valued at US$ 503 million in 2023 and is anticipated to reach US$ 629 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The top five global producers of twin-screw pumps are Colfax, ITT Bornemann, Flowserve, SPX Flow…
Global Strain Gauge Sensors Market Insights - Industry Share, Sales Projections, …
A strain gauge (or strain gage) is a sensor whose resistance varies with applied force; it converts force, pressure, tension, weight, etc., into a change in electrical resistance which can then be measured. When external forces are applied to a stationary object, stress and strain are the result. Stress is defined as the object"s internal Strain Gauge forces, and strain is defined as the displacement and deformation that occur.
The global…
Global Automatic Soap Dispensers Market Insights - Industry Share, Sales Project …
Automatic soap dispensers (also known as touchless or no-touch soap dispensers) dispense a controlled amount of soap solution (or a similar liquid such as a hand sanitizer). They are often used in conjunction with automatic faucets in public restrooms. They function to conserve the amount of soap used and stem infectious disease transmission.
The global Automatic Soap Dispensers market was valued at US$ million in 2023 and is anticipated to reach…
More Releases for IBS
Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs.
👉 Download our latest market insights:…
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR…
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA…
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide.
A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L…
HaCon and IBS combine expertise in railway operation
Hanover (2010-07-06). Two Hanoverian companies now combine their expertise in questions of railway operations: With effect from 1 July 2010, the HaCon Ingenieurgesellschaft mbH, took over the engineering firm for railway operating systems (Ingenieurbüro für Bahnbetriebssysteme GmbH – IBS). This way HaCon expanded its services to include the areas operation simulation, vehicle and personnel planning and construction operations planning.
This also includes consulting services concerning railway systems issues, such as travel…
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011.
The new bulkers, each with a capacity of 176,000 dwt, will be equipped…
